Cleveland Clinic and IBM have announced a landmark 10-year partnership based around quantum computing. This is designed to speed up discovery in healthcare and life sciences. The basis of the partnership is that IBM plans to install its first private-sector, on-premises quantum computing system in the U.S. at Cleveland Clinic. In the future, Cleveland Clinic also hopes to receive the first next-generation IBM 1,000+ qubit quantum system.
The project is partially funded by Swelife.
Contact – Researchers
Docent and associate professor, the University of Gothenburg and Sahlgrenska Academy, Institute of Neuroscience and Physiology, Department of Clinical Neuroscience
Docent and affiliated researcher, Chalmers University of Technology, Department of Microtechnology and Nanoscience — MC2
Project manager, Region Västra Götaland, Sahlgrenska University Hospital, Innovationsplattformen
Justin earned his PhD in physics in 2007 from the University of Southern California, USA. His thesis was on experimental quantum computing with superconducting qubits at NASA’s Jet Propulsion Laboratory. Having studied pre-med as an undergraduate, he expanded his skills in medical applications of superconducting quantum devices with a post-doc at the Chalmers University of Technology in the Department of Microtechnology and Nanoscience — MC2. Assistant and then associate professor positions followed at MedTech West and the Institute of Neuroscience and Physiology at the University of Gothenburg and Sahlgrenska Academy. He and his research group continue to advance next-generation functional neuroimaging technologies with Chalmers-developed superconducting quantum sensors. In 2021, he joined the Region Västra Götaland at Sahlgrenska University Hospital’s Innovation Platform (sv: Innovationsplattformen) where he now works on the Cleveland Clinic pre-study.
Image credit: Clara Ringqvist